Por: CNBC Health March 01, 2023
watch nowVIDEO1:5501:55FDA advisory panel votes in favor of adult RSV vaccine from GSK PLCThe Food and Drug Administration's independent panel of advisors on Wednesday recommended RSV vaccine for adults ages 60 and older, though they flagged potential safety issues over nervous system disorders that may be tied to the shot.Ten of the FDA advisors said the safety data on GSK's vaccine was adequate, while two said it was not. The... + full article
Time USA Health March 03, 2023
GSK Plc’s vaccine for won the support of a key panel of U.S. regulatory advisers for use in people aged 60 and older, as the drugmaker races against Pfizer Inc. to bring to market the first vaccine for RSV. The panel of 12 outside advisers to the Food and Drug Administration... + más
FDA advisors recommend GSK's RSV vaccine for older adults, but flag potential safety risks | CNBC
GSK vaccine for older adults granted FDA priority review | Fox Business
ABC7 USA Health March 02, 2023
vaccines for adults over the age of 60. The vaccine candidates, made by Pfizer and GlaxoSmithKline, could become the world's first approved vaccines against the common virus.The video featured is from a previous report.On Wednesday, committee members voted 10-2 in support... + más
Strong RSV vaccine data lifts hopes after years of futility | 10 WBNS
Strong RSV vaccine data lifts hopes after years of futility | WPLG Local 10
Fox Business USA Business November 02, 2022
Check out what's clicking on FoxBusiness.com GSK opened 2% higher in U.S. trading Wednesday but closed down 2%. Shares rose after the drugmaker reported financial results that beat Wall Street forecasts and announced the Food and Drug Administration had accepted a biologics... + más
GSK Raises 2022 Guidance as 3Q Sales Beat Expectations -- Update | MarketWatch
WPLG Local 10 USA Health November 01, 2022
New research shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals each fall.The preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be... + más
Strong RSV vaccine data lifts hopes after years of futility | ABC News
ABC7 USA Health November 01, 2022
New research shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals with wheezing babies each fall.The preliminary results buoy hope that after decades of failure and frustration, vaccines... + más
Pfizer Says Its Maternal RSV Vaccine Can Protect Newborns From Severe Illness | NBC 6 South Florida
ABC News USA Health November 01, 2022
New research shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals with wheezing babies each fall.The preliminary results buoy hope that after decades of failure and frustration, against RSV may... + más
10 WBNS USA Health November 01, 2022
NEW YORK — shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals each fall. The preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be... + más
About iurex | Privacy Policy | Disclaimer |